Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  pan-PI3K/mTOR inhibitor PQR309
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
PQR309 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: PQR309-005, NCI-2017-00729, NCT02669511
Start Over